Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer
Bladder Cancer · 2025-01 · 11 (1)
DOI: 10.1177/23523735251319185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bladder Cancer, online erschienen am 24.02.2025. Verfasst von Andrea Apolo und 31 weiteren Autor:innen. Beteiligte Einrichtung: Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
The National Cancer Institute organized a virtual Clinical Trials Planning Meeting (CTPM) on ‘Defining the next generation of clinical trials with combination therapies in non-muscle invasive bladder cancer (NMIBC)’ led by the Bladder Cancer Task Force of the NCI Genitourinary Cancers Steering Committee. The purpose of this meeting was to accelerate advances in clinical trials for patients with high-risk NMIBC. The meeting delivered a multidisciplinary expert consensus on optimal strategies for next-generation clinical trial designs in NMIBC with prioritization of combination therapies. Two clinical trial concepts were developed for potential implementation within the National Clinical Trials Network.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Department of Radiation Oncology, Springfield Clinic, Springfield, IL, USA.
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pathology and Laboratory Medicine, Genitourinary Pathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
- Patient Advocate, Bladder Cancer Advocacy Network, Bethesda, MD, USA.
ORCID-Profile: Hikmat Al-Ahmadie, Rick Bangs, Stephanie Cooper Greenberg, Noah M Hahn, Emma Hall, Jean Hoffman-Censits, Sophia C Kamran, Robert Lipman, David McConkey, Peter C Black
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Apolo, A., Baumann, B. C., Al-Ahmadie, H., Ballas, L., Bangs, R., Brothers, K., Greenberg, S. C., Delacroix, S., Dignam, J. J., Efstathiou, J. A., Feldman, A. S., Foster, J. C., Hahn, N. M., Hall, E., Hansel, D. E., Hoffman-Censits, J., Kamat, A. M., Kamran, S. C., Khani, F., …, & Black, P. C. (2025). Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer. Bladder Cancer, 11(1). https://doi.org/10.1177/23523735251319185
Vancouver
Apolo A, Baumann BC, Al-Ahmadie H, Ballas L, Bangs R, Brothers K, et al. Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer. Bladder Cancer. 2025;11(1). doi:10.1177/23523735251319185
BibTeX
@article{Apolo2025,
author = {Apolo, Andrea and Baumann, Brian C and Al-Ahmadie, Hikmat and Ballas, Leslie and Bangs, Rick and Brothers, Kenneth and Greenberg, Stephanie Cooper and Delacroix, Scott and Dignam, James J and Efstathiou, Jason A and Feldman, Adam S and Foster, Jared C and Hahn, Noah M and Hall, Emma and Hansel, Donna E and Hoffman-Censits, Jean and Kamat, Ashish M and Kamran, Sophia C and Khani, Francesca and Lerner, Seth P and Lipman, Robert and Mann, Bhupinder and McConkey, David and McKiernan, James and Rose, Tracy L and Smith, Angela B and Tangen, Catherine and Amiri, Abdul Tawab and Weinstock, Chana and West, Pamela J and Milowsky, Matthew I and Black, Peter C},
title = {Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer},
journal = {Bladder Cancer},
year = {2025},
volume = {11},
number = {1},
doi = {10.1177/23523735251319185}
}
EUVIMED